M&A Deal Summary

TJC Acquires PSG

On November 26, 2019, private equity firm TJC acquired chemicals company PSG from Arsenal Capital Partners

Acquisition Highlights
  • This is TJC’s 6th transaction in the Chemicals sector.
  • This is TJC’s 60th transaction in the United States.
  • This is TJC’s 6th transaction in Ohio.

M&A Deal Summary
Date 2019-11-26
Target PSG
Sector Chemicals
Buyer(s) TJC
Sellers(s) Arsenal Capital Partners
Deal Type Secondary Buyout

Target

PSG

Cleveland, Ohio, United States
PSG is a manufacturer of proprietary and custom polymer additives, dispersions, and performance chemicals for the rubber, plastic, and engineered wood industries. PSG offers a variety of customer-centric solutions that improve polymer processing, increase surface protection, and enhance product performance. PSG was founded in 2015 and is based in Cleveland, Ohio.

Search 200,500 Deals Now

SEARCH BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Try For Free 7-Day Free Trial

Buyer(S) 1

Buyer

TJC

New York, New York, United States

Investor Investor Investor Investor Investor

Category Private Equity Firm
Founded 1982
PE ASSETS 14.0B USD
Size Mega
Type Sector Agnostic
DESCRIPTION

TJC is a private investment firm that specializes in acquiring North American middle-market businesses operating in basic industries. TJC specifically looks to provide liquidity for shareholders, raise capital for corporate growth and 'create significant equity opportunities for key management'. TJC will consider opportunities valued from $100 million to $2 billion in a wide variety of industries. Sectors of interest include aerospace/defense, automotive, building products, chemicals, consumer products, distribution, energy, financial services, healthcare, industrial products, insurance, metals, packaging, retail, transportation/logistics, and telecom. TJC was formerly known as The Jordan Company. The Firm was formed in 1982 and is based in New York City.

DEAL STATS #
Overall 62 of 93
Sector (Chemicals) 6 of 8
Type (Secondary Buyout) 20 of 34
State (Ohio) 6 of 6
Country (United States) 60 of 89
Year (2019) 7 of 8
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2019-09-25 Invo Healthcare

Tampa, Pennsylvania, United States

Invo HealthCare is a provider of outsourced clinical services for special needs children in 23 states. It operates through two divisions that serve the needs of preschool children (3-5) and school age children (K-12). In addition Invo’s early intervention division provides service delivery to children from birth to 3 years. Invo Healthcare was founded in 1993 and is based in Tampa, Pennsylvania.

Sell -
FOLLOWING DEAL
DATE TARGET DEAL TYPE VALUE
2019-12-03 Silvus

Los Angeles, California, United States

Silvus develops and manufactures mobile communications datalinks (branded StreamCaster) that are reshaping traditional broadband wireless connectivity. Primarily used in law enforcement, unmanned systems, tactical and other commercial/industrial applications, Silvus’ StreamCaster radios and their proprietary waveform overcome traditional network challenges and facilitate data communication in harsh environments, without the need for fixed infrastructure. Silvus was founded in 2004 and is based in Los Angeles, California.

Buy -

Seller(S) 1

SELLER

Arsenal Capital Partners

New York, New York, United States

Investor Investor Investor Investor Investor

Category Private Equity Firm
Founded 2000
PE ASSETS 10.0B USD
Size Mega
Type Sector Agnostic
DESCRIPTION

Arsenal Capital Partners is a private equity firm focused on middle-market healthcare, specialty industrial, and financial service companies. Specifically, Arsenal looks to acquire businesses in the areas of specialty chemicals, aerospace/defense, transportation, environmental services, business services, insurance, asset management, financial technology, medical products, healthcare IT, and healthcare contract research/manufacturing. The Firm typically seeks to commit $50 to $300 million per investment in profitable businesses with at least $10 million of EBITDA. Funds are generally used to support buyouts, recapitalizations, growth financings, consolidations, and divestitures. The Firm avoids investing in companies reliant on high levels of technology. Arsenal Capital Partners was formed in 2000 and is headquartered in New York City.

DEAL STATS #
Overall 29 of 35
Sector (Chemicals) 11 of 12
Type (Secondary Buyout) 14 of 16
State (Ohio) 3 of 3
Country (United States) 28 of 32
Year (2019) 3 of 3
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2019-11-14 WCG

Princeton, New Jersey, United States

WCG is a provider of regulatory and ethical review services for human research. The pioneer of independent ethical review, WCG continues to drive ingenuity in the clinical research space. WCG delivers transformational solutions that stimulate growth, foster compliance and maximize efficiency for those who perform clinical trials. WCG was founded in 2012 and is based in Princeton, New Jersey.

Sell -
FOLLOWING DEAL
DATE TARGET DEAL TYPE VALUE
2020-02-26 Lumanity

Bethesda, Maryland, United States

Lumanity applies incisive thinking and decisive action to cut through complex situations and deliver transformative outcomes to accelerate and optimize access to medical advances. With deep experience in medical, commercial, and regulatory affairs, the company transforms data and information into real-world insights and evidence that powers successful commercialization and empowers patients, providers, payers, and regulators to take timely and decisive action. Lumanity was formed in 2020 and is based in Bethesda, Maryland.

Buy -
Mergr

Product

Company

Legal